These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 14240318)
21. [Impairment of the desmofibrinogenic activity of the fibrin stabilizing factor (FSF) due to free thiol group (SH) deficiency in middle-aged and old persons]. Zuch A; Buluk K Acta Haematol Pol; 1980; 11(3):129-35. PubMed ID: 7445918 [No Abstract] [Full Text] [Related]
22. [Case of factor XIII deficiency]. Jinmae G; Tanaka K; Ige K; Okuma H; Imaoka M Nihon Ketsueki Gakkai Zasshi; 1970 Oct; 33(5):692-6. PubMed ID: 5535826 [No Abstract] [Full Text] [Related]
23. Congenital deficiency of fibrin-stabilizing factor. Report of a case and family study. Zahir M JAMA; 1969 Jan; 207(4):751-3. PubMed ID: 5818197 [No Abstract] [Full Text] [Related]
24. [Hyperlipoproteinemia and fibrin stabilization using blood factor 13]. Zöller H; Fromme K; Gross W Med Welt; 1974 Aug; 33(34):1303-4. PubMed ID: 4369583 [No Abstract] [Full Text] [Related]
25. Congenital deficiency of fibrin-stabilizing factor (factor XIII). A report of the first case from Latin America. Arends T; Guevara JM; Rangel JR Acta Haematol; 1968; 40(6):329-35. PubMed ID: 4978700 [No Abstract] [Full Text] [Related]
26. A comparison of the mechanical, kinetic, and biochemical properties of fibrin clots formed with two different fibrin sealants. Hickerson WL; Nur I; Meidler R Blood Coagul Fibrinolysis; 2011 Jan; 22(1):19-23. PubMed ID: 21150581 [TBL] [Abstract][Full Text] [Related]
32. [Hemorrhagic disease due to a defect of the fibrin stabilizing factor]. Ottaviani P; Mandelli F; Fontana L; Morelli R Recenti Prog Med; 1966 May; 40(5):377-407. PubMed ID: 6012638 [No Abstract] [Full Text] [Related]
33. [Duration of life of the fibrin stabilizing factor (factor 13). Therapeutic indications]. Josso F; Petrova M; Ménaché D; Sizonenko P Transfusion (Paris); 1966; 9(4):343-6. PubMed ID: 5966234 [No Abstract] [Full Text] [Related]
34. Relative effects of plasma, fibrinogen concentrate, and factor XIII on ROTEM coagulation profiles in an in vitro model of massive transfusion in trauma. Schmidt DE; Halmin M; Wikman A; Östlund A; Ågren A Scand J Clin Lab Invest; 2017 Oct; 77(6):397-405. PubMed ID: 28632435 [TBL] [Abstract][Full Text] [Related]
35. Estimation of plasma fibrin-stabilizing factor in families showing congenital deficiencies. Losowsky MS; Hall R Clin Sci; 1966 Feb; 30(1):171-8. PubMed ID: 5910931 [No Abstract] [Full Text] [Related]
36. The monoiodoacetate (MIA) tolerance test, a new quantitative method for the fibrin stabilizing factor (factor 13) assay. Sigg P Thromb Diath Haemorrh; 1966 Jan; 15(1):238-51. PubMed ID: 5919804 [No Abstract] [Full Text] [Related]